TSE:WEEDCanopy Growth Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Canopy Growth Corp Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add C$21.23 +0.97 (+4.79 %) (As of 04/7/2020 10:17 AM ET) Add Compare Share Today's RangeC$20.92Now: C$21.23▼C$21.6950-Day RangeC$14.14MA: C$21.63▼C$29.9852-Week RangeC$12.96Now: C$21.23▼C$70.98Volume580,285 shsAverage Volume2.95 million shsMarket CapitalizationC$7.42 billionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartInsider TradesHeadlinesSocial Media Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names. It also offers its products through Tweed Main Street, a single online platform that enables registered patients to purchase medicinal cannabis from various producers across various brands. Canopy Growth Corporation has a clinical research partnership with NEEKA Health Canada to investigate the efficacy of cannabinoids for the treatment of post-concussion neurological diseases in former NHL players; and partnership with Parent Action on Drugs. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.Read More Beat the Market (BTM) Rank™ 3.3 Analyst's Opinion Consensus RatingCanopy Growth has received a consensus rating of Buy. The company's average rating score is 2.56, and is based on 5 buy ratings, 4 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of C$44.15, Canopy Growth has a potential upside of 108.0% from its current price of C$21.23.Amount of Analyst CoverageCanopy Growth has only been the subject of 4 research reports in the past 90 days. Previous Next 2.6 Community Rank Outperform VotesCanopy Growth has received 629 “outperform” votes. (Add your “outperform” vote.)Underperform VotesCanopy Growth has received 579 “underperform” votes. (Add your “underperform” vote.)Community SentimentCanopy Growth has received 52.07% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Canopy Growth and other stocks. Vote “Outperform” if you believe WEED will outperform the S&P 500 over the long term. Vote “Underperform” if you believe WEED will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldCanopy Growth does not currently pay a dividend.Dividend GrowthCanopy Growth does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Canopy Growth insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Earnings GrowthEarnings for Canopy Growth are expected to decrease by -100.00% in the coming year, from C($1.26) to C$0.00 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Canopy Growth is -3.47, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Canopy Growth is -3.47, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioDue to a projected decrease in earnings for Canopy Growth, their PEG ratio cannot be calculated.Price to Book Value per Share RatioCanopy Growth has a P/B Ratio of 1.41. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next Analyst Opinion: 3.3Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.18 out of 5 stars Industry, Sector and Symbol Stock Exchange TSE Industry Drug Manufacturers - Specialty & Generic Sub-IndustryCannabis SectorMedical Current SymbolTSE:WEED Previous Symbol CUSIPN/A CIKN/A Webhttp://www.canopygrowth.com/ Phone+1-613-5999600Debt Debt-to-Equity Ratio12.07 Current Ratio7.59 Quick Ratio5.71Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E Growth-0.32 Sales & Book Value Annual SalesC$384.91 million Price / Sales19.29 Cash FlowC$7.38 per share Price / Cash Flow2.88 Book ValueC$15.05 per share Price / Book1.41Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees2,700 Outstanding Shares349,651,000Market CapC$7.42 billion Next Earnings Date5/29/2020 (Estimated) OptionableNot Optionable Receive WEED News and Ratings via Email Sign-up to receive the latest news and ratings for WEED and its competitors with MarketBeat's FREE daily newsletter. TSX:WEED Rates by TradingView Canopy Growth (TSE:WEED) Frequently Asked Questions How has Canopy Growth's stock been impacted by COVID-19 (Coronavirus)? Canopy Growth's stock was trading at C$18.33 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, WEED shares have increased by 15.8% and is now trading at C$21.23. View which stocks have been mosted impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Canopy Growth? 9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Canopy Growth in the last year. There are currently 4 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Canopy Growth. When is Canopy Growth's next earnings date? Canopy Growth is scheduled to release its next quarterly earnings announcement on Friday, May 29th 2020. View our earnings forecast for Canopy Growth. What price target have analysts set for WEED? 9 equities research analysts have issued 12-month price objectives for Canopy Growth's shares. Their forecasts range from C$21.00 to C$75.00. On average, they anticipate Canopy Growth's stock price to reach C$44.15 in the next year. This suggests a possible upside of 108.0% from the stock's current price. View analysts' price targets for Canopy Growth. Has Canopy Growth been receiving favorable news coverage? Headlines about WEED stock have trended very negative recently, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Canopy Growth earned a daily sentiment score of -3.3 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View the latest news aboutCanopy Growth. Who are some of Canopy Growth's key competitors? Some companies that are related to Canopy Growth include Canopy Growth (CGC), Innovative Industrial Properties (IIPR), OrganiGram (OGI), Emblem (EMC), ICC Labs (ICC), Bioventix (BVXP), GrowGeneration (GRWG), 22nd Century Group (XXII), KushCo (KSHB), General Cannabis (CANN), mCig (MCIG), Terra Tech (TRTC), Grow Capital (GRWC), Nemus Bioscience (NMUS) and Leafbuyer Technologies (LBUY). What other stocks do shareholders of Canopy Growth own? Based on aggregate information from My MarketBeat watchlists, some companies that other Canopy Growth investors own include Canopy Growth (CGC), Aurora Cannabis (ACB), Aphria (APHA), Aurora Cannabis (ACB), Auxly Cannabis Group (CBWTF), KushCo (KSHB), Cronos Group (CRON), Aurora Cannabis (ACBFF), GW Pharmaceuticals PLC- (GWPH) and Alibaba Group (BABA). Who are Canopy Growth's key executives? Canopy Growth's management team includes the following people: Mr. Bruce A. Linton, Co-Founder, Chairman & Co-CEO (Age 52)Mr. Mark Anthony Nicholas Zekulin, Pres & Co-CEOMr. Timothy Rob Saunders, Exec. OfficerMr. Rade Kovacevic, Exec. VPMr. Mike Lee, Acting Chief Financial Officer What is Canopy Growth's stock symbol? Canopy Growth trades on the Toronto Stock Exchange (TSX) under the ticker symbol "WEED." How do I buy shares of Canopy Growth? Shares of WEED and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab. What is Canopy Growth's stock price today? One share of WEED stock can currently be purchased for approximately C$21.23. How big of a company is Canopy Growth? Canopy Growth has a market capitalization of C$7.42 billion and generates C$384.91 million in revenue each year. Canopy Growth employs 2,700 workers across the globe. View additional information about Canopy Growth. What is Canopy Growth's official website? The official website for Canopy Growth is http://www.canopygrowth.com/. How can I contact Canopy Growth? Canopy Growth's mailing address is 1 Hershey Dr, SMITHS FALLS, ON K7A 0A8, Canada. The company can be reached via phone at +1-613-5999600. This page was last updated on 4/7/2020 by MarketBeat.com StaffFeatured Article: What is a Candlestick Chart?
